Purdue Pharma

Latest stories

6d
The Globe and Mail
Ontario to stop paying for high-dose opioidsstopped funding the country’s most widely prescribed painkiller. OxyContin, a b
Ontario to stop paying for high-dose opioids
The Globe and Mail / Posted 6 days ago
stopped funding the country’s most widely prescribed painkiller. OxyContin, a brand-name version of oxycodone made by Purdue Pharma, was once the top-selling, long-acting opioid in Canada. But it became a lightning rod in the early 2000s as... Read more
2 related stories
10d
The Neosho Daily News
Matthew T. Mangino: Opioid abuse out of control, but not newabout the scourge of OxyContin abuse. At the time, my office led a series of wo
Matthew T. Mangino: Opioid abuse out of control, but not new
The Neosho Daily News / Posted 10 days ago
about the scourge of OxyContin abuse. At the time, my office led a series of workshops with the manufacturer of OxyContin, Purdue Pharma, to educate health care providers, law enforcement and the public about the potential dangers of opioid abuse.... Read more
16 related stories
10d
The Chronicle Express
Matthew T. Mangino: Opioid abuse out of control, but not newabout the scourge of OxyContin abuse. At the time, my office led a series of wo
Matthew T. Mangino: Opioid abuse out of control, but not new
The Chronicle Express / Posted 10 days ago
about the scourge of OxyContin abuse. At the time, my office led a series of workshops with the manufacturer of OxyContin, Purdue Pharma, to educate health care providers, law enforcement and the public about the potential dangers of opioid abuse.... Read more
16 related stories
10d
Kirksville Daily Express
Matthew T. Mangino: Opioid abuse out of control, but not newabout the scourge of OxyContin abuse. At the time, my office led a series of wo
Matthew T. Mangino: Opioid abuse out of control, but not new
Kirksville Daily Express / Posted 10 days ago
about the scourge of OxyContin abuse. At the time, my office led a series of workshops with the manufacturer of OxyContin, Purdue Pharma, to educate health care providers, law enforcement and the public about the potential dangers of opioid abuse.... Read more
16 related stories
10d
Linn County Leader
Matthew T. Mangino: Opioid abuse out of control, but not newabout the scourge of OxyContin abuse. At the time, my office led a series of wo
Matthew T. Mangino: Opioid abuse out of control, but not new
Linn County Leader / Posted 10 days ago
about the scourge of OxyContin abuse. At the time, my office led a series of workshops with the manufacturer of OxyContin, Purdue Pharma, to educate health care providers, law enforcement and the public about the potential dangers of opioid abuse.... Read more
16 related stories
10d
ChillicotheNews
Matthew T. Mangino: Opioid abuse out of control, but not newabout the scourge of OxyContin abuse. At the time, my office led a series of wo
Matthew T. Mangino: Opioid abuse out of control, but not new
ChillicotheNews / Posted 10 days ago
about the scourge of OxyContin abuse. At the time, my office led a series of workshops with the manufacturer of OxyContin, Purdue Pharma, to educate health care providers, law enforcement and the public about the potential dangers of opioid abuse.... Read more
16 related stories
11d
The Newton Kansan
Matthew T. Mangino: Opioid abuse out of control, but not newabout the scourge of OxyContin abuse. At the time, my office led a series of wo
Matthew T. Mangino: Opioid abuse out of control, but not new
The Newton Kansan / Posted 11 days ago
about the scourge of OxyContin abuse. At the time, my office led a series of workshops with the manufacturer of OxyContin, Purdue Pharma, to educate health care providers, law enforcement and the public about the potential dangers of opioid abuse.... Read more
16 related stories
11d
Boonville Daily News
Matthew T. Mangino: Opioid abuse out of control, but not newabout the scourge of OxyContin abuse. At the time, my office led a series of wo
Matthew T. Mangino: Opioid abuse out of control, but not new
Boonville Daily News / Posted 11 days ago
about the scourge of OxyContin abuse. At the time, my office led a series of workshops with the manufacturer of OxyContin, Purdue Pharma, to educate health care providers, law enforcement and the public about the potential dangers of opioid abuse.... Read more
16 related stories
11d
Mount Shasta Area Newspapers
Matthew T. Mangino: Opioid abuse out of control, but not newabout the scourge of OxyContin abuse. At the time, my office led a series of wo
Matthew T. Mangino: Opioid abuse out of control, but not new
Mount Shasta Area Newspapers / Posted 11 days ago
about the scourge of OxyContin abuse. At the time, my office led a series of workshops with the manufacturer of OxyContin, Purdue Pharma, to educate health care providers, law enforcement and the public about the potential dangers of opioid abuse.... Read more
16 related stories
12d
Kewanee Star Courier
Matthew T. Mangino: Opioid abuse out of control, but not newabout the scourge of OxyContin abuse. At the time, my office led a series of wo
Matthew T. Mangino: Opioid abuse out of control, but not new
Kewanee Star Courier / Posted 12 days ago
about the scourge of OxyContin abuse. At the time, my office led a series of workshops with the manufacturer of OxyContin, Purdue Pharma, to educate health care providers, law enforcement and the public about the potential dangers of opioid abuse.... Read more
16 related stories
13d
Benton Evening News
Matthew T. Mangino: Opioid abuse out of control, but not newabout the scourge of OxyContin abuse. At the time, my office led a series of wo
Matthew T. Mangino: Opioid abuse out of control, but not new
Benton Evening News / Posted 13 days ago
about the scourge of OxyContin abuse. At the time, my office led a series of workshops with the manufacturer of OxyContin, Purdue Pharma, to educate health care providers, law enforcement and the public about the potential dangers of opioid abuse.... Read more
16 related stories
13d
The Harrisburg Daily Register
Matthew T. Mangino: Opioid abuse out of control, but not newabout the scourge of OxyContin abuse. At the time, my office led a series of wo
Matthew T. Mangino: Opioid abuse out of control, but not new
The Harrisburg Daily Register / Posted 13 days ago
about the scourge of OxyContin abuse. At the time, my office led a series of workshops with the manufacturer of OxyContin, Purdue Pharma, to educate health care providers, law enforcement and the public about the potential dangers of opioid abuse.... Read more
16 related stories
13d
CambridgeChronicle.com
Matthew T. Mangino: Opioid abuse out of control, but not newabout the scourge of OxyContin abuse. At the time, my office led a series of wo
Matthew T. Mangino: Opioid abuse out of control, but not new
CambridgeChronicle.com / Posted 13 days ago
about the scourge of OxyContin abuse. At the time, my office led a series of workshops with the manufacturer of OxyContin, Purdue Pharma, to educate health care providers, law enforcement and the public about the potential dangers of opioid abuse.... Read more
16 related stories
13d
GalvaNews
Opioid abuse out of control, but not newabout the scourge of OxyContin abuse. At the time, my office led a series of wo
Opioid abuse out of control, but not new
GalvaNews / Posted 13 days ago
about the scourge of OxyContin abuse. At the time, my office led a series of workshops with the manufacturer of OxyContin, Purdue Pharma, to educate health care providers, law enforcement and the public about the potential dangers of opioid abuse.... Read more
16 related stories
13d
Duquoin.com
Matthew T. Mangino: Opioid abuse out of control, but not newabout the scourge of OxyContin abuse. At the time, my office led a series of wo
Matthew T. Mangino: Opioid abuse out of control, but not new
Duquoin.com / Posted 13 days ago
about the scourge of OxyContin abuse. At the time, my office led a series of workshops with the manufacturer of OxyContin, Purdue Pharma, to educate health care providers, law enforcement and the public about the potential dangers of opioid abuse.... Read more
16 related stories
13d
AledoTimesRecord.com
Opioid abuse out of control, but not newabout the scourge of OxyContin abuse. At the time, my office led a series of wo
Opioid abuse out of control, but not new
AledoTimesRecord.com / Posted 13 days ago
about the scourge of OxyContin abuse. At the time, my office led a series of workshops with the manufacturer of OxyContin, Purdue Pharma, to educate health care providers, law enforcement and the public about the potential dangers of opioid abuse.... Read more
16 related stories
13d
Aljazeera
Can the US end its addiction to painkillers?federal officials have clamped down on overprescribing and "pill mills" by trai
Can the US end its addiction to painkillers?
Aljazeera / Posted 13 days ago
federal officials have clamped down on overprescribing and "pill mills" by training doctors and in the courts. In 2007, Purdue Pharma, the maker of the painkiller OxyContin, paid a $634m fine for misrepresenting the drug's addictiveness. In... Read more
15d
Wired News
The History of Trial by Combat, and Other Stories You Missed This Weekmore than 1 million OxyContin pills ended up in the hands of criminals and addi
The History of Trial by Combat, and Other Stories You Missed This Week
Wired News / Posted 15 days ago
more than 1 million OxyContin pills ended up in the hands of criminals and addicts. They also ask the question: What did Purdue Pharma know about the people who doled out their addictive product like Tic Tacs? Question: How many people does it... Read more
18d
Hartford Courant
Blumenthal May Seek Hearing On OxyContin MakerHARTFORD – Sen. Richard Blumenthal first challenged Stamford drug-maker Purdue
Blumenthal May Seek Hearing On OxyContin Maker
Hartford Courant / Posted 18 days ago
HARTFORD – Sen. Richard Blumenthal first challenged Stamford drug-maker Purdue Pharma's marketing of the addictive pain killer OxyContin in 2001. With a Los Angeles Times investigation raising new questions about the company's practices, Blumenthal... Read more
5 related stories
19d
Boston Globe
Pfizer, in pact with Chicago, agrees to help blunt opioid crisisthis: The deal was reached as Chicago officials press a two-year-old lawsuit a
Pfizer, in pact with Chicago, agrees to help blunt opioid crisis
Boston Globe / Posted 19 days ago
this: The deal was reached as Chicago officials press a two-year-old lawsuit against five other drug makers — including Purdue Pharma and Johnson & Johnson — for allegedly misleading the public about the risks of opioids and causing a rise in... Read more
19d
KESQ Palm Springs
The other tragedy behind Prince's deathacute injuries such as fractures, and for pain from the tissue damage caused by
The other tragedy behind Prince's death
KESQ Palm Springs / Posted 19 days ago
acute injuries such as fractures, and for pain from the tissue damage caused by cancer. But that all changed in 1996 when Purdue Pharma introduced its new, extended release oxycodone preparation -- OxyContin. Instead of just focusing on patients... Read more
19d
Naked Capitalism
Credentialism and Corruption: The Opioid Epidemic and "the Looting Professional Class"through the pharmaceutical supply chain. The “Looting Professional Class” as a
Credentialism and Corruption: The Opioid Epidemic and "the Looting Professional Class"
Naked Capitalism / Posted 19 days ago
through the pharmaceutical supply chain. The “Looting Professional Class” as a Transmission Vector Starting in 1996, Purdue Pharma expanded its sales department to coincide with the debut of its new drug. According to an article published in... Read more
5 related stories
19d
Los Angeles Times
How 1.1 Million OxyContins Made It to the Streets. Trying Times in Dallas.Times. Here are some story lines I don't want you to miss today. How 1.1 Milli
How 1.1 Million OxyContins Made It to the Streets. Trying Times in Dallas.
Los Angeles Times / Posted 19 days ago
Times. Here are some story lines I don't want you to miss today. How 1.1 Million OxyContins Made It to the Streets: What Purdue Pharma Knew Inside Lake Medical’s leased office space near MacArthur Park, a doctor prescribed tens of thousands of... Read more
19d
MedCity News
Purdue said to have hidden evidence of OxyContin diversion, more Theranos dramaPurdue Pharma reportedly knew about all kinds of illegal distribution and diver
Purdue said to have hidden evidence of OxyContin diversion, more Theranos drama
MedCity News / Posted 19 days ago
Purdue Pharma reportedly knew about all kinds of illegal distribution and diversion of OxyContin, but kept it under wraps for more than a decade. “A former Purdue executive, who monitored pharmacies for criminal activity, acknowledged that even when... Read more
20d
Chicago Tribune
Inside an L.A. OxyContin ring that pushed more than 1 million pills. What the drugmaker knewshe had prescribed more than 73,000, with a street value of nearly $6 million.
Inside an L.A. OxyContin ring that pushed more than 1 million pills. What the drugmaker knew
Chicago Tribune / Posted 20 days ago
she had prescribed more than 73,000, with a street value of nearly $6 million. At its headquarters in Stamford, Conn., Purdue Pharma, the maker of OxyContin, tracked the surge in prescriptions. A sales manager went to check out the clinic and... Read more
5 related stories
20d
Baltimore Sun
How black-market OxyContin spurred a town's descent into crime, addiction and heartbreaksent couriers aboard planes to Seattle with pills strapped to their bodies. At
How black-market OxyContin spurred a town's descent into crime, addiction and heartbreak
Baltimore Sun / Posted 20 days ago
sent couriers aboard planes to Seattle with pills strapped to their bodies. At the time OxyContin was ravaging Everett, Purdue Pharma, the maker of OxyContin, was tracking the voluminous prescriptions written by Lake Medical’s doctors as well as... Read more
22d
Baltimore Sun
Painkiller panel drops experts linked to pharma industrydrug makers dating back at least two decades, he wrote. Three residencies she r
Painkiller panel drops experts linked to pharma industry
Baltimore Sun / Posted 22 days ago
drug makers dating back at least two decades, he wrote. Three residencies she ran between 1997 and 2004 were funded by Purdue Pharma, while Purdue Frederick funded three others. The companies gave a total of $253,500, according to the letter.... Read more
3 related stories
23d
Fortune
Could a Molecular ‘On-Off Switch for Agony’ Lead to a Safer Painkiller?Pharmaceuticals to get its hands on some Nav1.7 inhibitors. Amgenamgn is in the
Could a Molecular ‘On-Off Switch for Agony’ Lead to a Safer Painkiller?
Fortune / Posted 23 days ago
Pharmaceuticals to get its hands on some Nav1.7 inhibitors. Amgenamgn is in the early stages with a similar project. And Purdue Pharma, the controversial maker of opioid therapy OxyContin, launched a joint venture last year specifically focused... Read more
23d
The Financial Express
Painkiller panel drops experts linked to pharmaceutical industryPress. Wyden’s letter notes that the society has a ”corporate council” of phar
Painkiller panel drops experts linked to pharmaceutical industry
The Financial Express / Posted 23 days ago
Press. Wyden’s letter notes that the society has a ”corporate council” of pharmaceutical manufacturers – including Purdue Pharma, Pfizer Inc. and Teva Pharmaceuticals – that contributed at least $132,500 to the group, according to online... Read more
3 related stories
24d
SaukValley.com
Pfizer agrees to note addiction risks in opioid marketingtargeted the elderly and veterans, leading to “catastrophic results.” The five
Pfizer agrees to note addiction risks in opioid marketing
SaukValley.com / Posted 24 days ago
targeted the elderly and veterans, leading to “catastrophic results.” The five companies are Janssen Pharmaceuticals, Purdue Pharma, Actavis, Endo Health Solutions Inc., and Teva Pharmaceutical Industries. The drugmakers have asked a federal... Read more
54 related stories
24d
Brandon Sun
Painkiller panel drops experts linked to pharma industryPress. Wyden's letter notes that the society has a "corporate council" of phar
Painkiller panel drops experts linked to pharma industry
Brandon Sun / Posted 24 days ago
Press. Wyden's letter notes that the society has a "corporate council" of pharmaceutical manufacturers — including Purdue Pharma, Pfizer Inc. and Teva Pharmaceuticals — that contributed at least $132,500 to the group, according to online... Read more
3 related stories
24d
The Norwich Bulletin
Pfizer agrees to limit opioid marketingof this opioid mess is not likely to be successful," she said.Aggressive, somet
Pfizer agrees to limit opioid marketing
The Norwich Bulletin / Posted 24 days ago
of this opioid mess is not likely to be successful," she said.Aggressive, sometimes fraudulent marketing of OxyContin by Purdue Pharma, one of the targets of Chicago's lawsuit, is widely blamed for the rapid growth of painkiller use across the... Read more
54 related stories
24d
The Hendersonville Times-News
Pfizer agrees to note addiction risks in opioid marketingtargeted the elderly and veterans, leading to "catastrophic results." The five
Pfizer agrees to note addiction risks in opioid marketing
The Hendersonville Times-News / Posted 24 days ago
targeted the elderly and veterans, leading to "catastrophic results." The five companies are Janssen Pharmaceuticals, Purdue Pharma, Actavis, Endo Health Solutions Inc., and Teva Pharmaceutical Industries. The drugmakers have asked a federal... Read more
54 related stories
24d
WSOC-TV Charlotte
Chicago says Pfizer agrees to disclose risks of opioidstargeted the elderly and veterans, leading to "catastrophic results." The five
Chicago says Pfizer agrees to disclose risks of opioids
WSOC-TV Charlotte / Posted 24 days ago
targeted the elderly and veterans, leading to "catastrophic results." The five companies are Janssen Pharmaceuticals, Purdue Pharma, Actavis, Endo Health Solutions Inc., and Teva Pharmaceutical Industries. The drugmakers have asked a federal... Read more
54 related stories
24d
KTVN Reno
Pfizer agrees to note addiction risks in opioid marketingtargeted the elderly and veterans, leading to "catastrophic results." The five
Pfizer agrees to note addiction risks in opioid marketing
KTVN Reno / Posted 24 days ago
targeted the elderly and veterans, leading to "catastrophic results." The five companies are Janssen Pharmaceuticals, Purdue Pharma, Actavis, Endo Health Solutions Inc., and Teva Pharmaceutical Industries. The drugmakers have asked a federal... Read more
54 related stories
24d
KTRE Lufkin and Nacogdoches
Pfizer agrees to note addiction risks in opioid marketingtargeted the elderly and veterans, leading to "catastrophic results." The five
Pfizer agrees to note addiction risks in opioid marketing
KTRE Lufkin and Nacogdoches / Posted 24 days ago
targeted the elderly and veterans, leading to "catastrophic results." The five companies are Janssen Pharmaceuticals, Purdue Pharma, Actavis, Endo Health Solutions Inc., and Teva Pharmaceutical Industries. The drugmakers have asked a federal... Read more
54 related stories
24d
Hawaii News Now
Pfizer agrees to note addiction risks in opioid marketingtargeted the elderly and veterans, leading to "catastrophic results." The five
Pfizer agrees to note addiction risks in opioid marketing
Hawaii News Now / Posted 24 days ago
targeted the elderly and veterans, leading to "catastrophic results." The five companies are Janssen Pharmaceuticals, Purdue Pharma, Actavis, Endo Health Solutions Inc., and Teva Pharmaceutical Industries. The drugmakers have asked a federal... Read more
54 related stories
24d
WALB Albany
Pfizer agrees to note addiction risks in opioid marketingtargeted the elderly and veterans, leading to "catastrophic results." The five
Pfizer agrees to note addiction risks in opioid marketing
WALB Albany / Posted 24 days ago
targeted the elderly and veterans, leading to "catastrophic results." The five companies are Janssen Pharmaceuticals, Purdue Pharma, Actavis, Endo Health Solutions Inc., and Teva Pharmaceutical Industries. The drugmakers have asked a federal... Read more
54 related stories
24d
KSWO Lawton-Wichita Falls
Pfizer agrees to note addiction risks in opioid marketingtargeted the elderly and veterans, leading to "catastrophic results." The five
Pfizer agrees to note addiction risks in opioid marketing
KSWO Lawton-Wichita Falls / Posted 24 days ago
targeted the elderly and veterans, leading to "catastrophic results." The five companies are Janssen Pharmaceuticals, Purdue Pharma, Actavis, Endo Health Solutions Inc., and Teva Pharmaceutical Industries. The drugmakers have asked a federal... Read more
54 related stories
24d
WTVM 9 Columbus
Pfizer agrees to note addiction risks in opioid marketingtargeted the elderly and veterans, leading to "catastrophic results." The five
Pfizer agrees to note addiction risks in opioid marketing
WTVM 9 Columbus / Posted 24 days ago
targeted the elderly and veterans, leading to "catastrophic results." The five companies are Janssen Pharmaceuticals, Purdue Pharma, Actavis, Endo Health Solutions Inc., and Teva Pharmaceutical Industries. The drugmakers have asked a federal... Read more
54 related stories
24d
KLTV 7 Tyler
Pfizer agrees to note addiction risks in opioid marketingtargeted the elderly and veterans, leading to "catastrophic results." The five
Pfizer agrees to note addiction risks in opioid marketing
KLTV 7 Tyler / Posted 24 days ago
targeted the elderly and veterans, leading to "catastrophic results." The five companies are Janssen Pharmaceuticals, Purdue Pharma, Actavis, Endo Health Solutions Inc., and Teva Pharmaceutical Industries. The drugmakers have asked a federal... Read more
54 related stories
24d
WSB-TV 2 Atlanta
Chicago says Pfizer agrees to disclose risks of opioidstargeted the elderly and veterans, leading to "catastrophic results." The five
Chicago says Pfizer agrees to disclose risks of opioids
WSB-TV 2 Atlanta / Posted 24 days ago
targeted the elderly and veterans, leading to "catastrophic results." The five companies are Janssen Pharmaceuticals, Purdue Pharma, Actavis, Endo Health Solutions Inc., and Teva Pharmaceutical Industries. The drugmakers have asked a federal... Read more
54 related stories
24d
WGEM Quincy
Pfizer agrees to note addiction risks in opioid marketingtargeted the elderly and veterans, leading to "catastrophic results." The five
Pfizer agrees to note addiction risks in opioid marketing
WGEM Quincy / Posted 24 days ago
targeted the elderly and veterans, leading to "catastrophic results." The five companies are Janssen Pharmaceuticals, Purdue Pharma, Actavis, Endo Health Solutions Inc., and Teva Pharmaceutical Industries. The drugmakers have asked a federal... Read more
54 related stories
24d
KFJX Pittsburg
Pfizer agrees to note addiction risks in opioid marketingtargeted the elderly and veterans, leading to "catastrophic results." The five
Pfizer agrees to note addiction risks in opioid marketing
KFJX Pittsburg / Posted 24 days ago
targeted the elderly and veterans, leading to "catastrophic results." The five companies are Janssen Pharmaceuticals, Purdue Pharma, Actavis, Endo Health Solutions Inc., and Teva Pharmaceutical Industries. The drugmakers have asked a federal... Read more
54 related stories
24d
WDAM-TV Hattiesburg
Pfizer agrees to note addiction risks in opioid marketingtargeted the elderly and veterans, leading to "catastrophic results." The five
Pfizer agrees to note addiction risks in opioid marketing
WDAM-TV Hattiesburg / Posted 24 days ago
targeted the elderly and veterans, leading to "catastrophic results." The five companies are Janssen Pharmaceuticals, Purdue Pharma, Actavis, Endo Health Solutions Inc., and Teva Pharmaceutical Industries. The drugmakers have asked a federal... Read more
54 related stories
24d
WECT 6 Wilmington
Pfizer agrees to note addiction risks in opioid marketingtargeted the elderly and veterans, leading to "catastrophic results." The five
Pfizer agrees to note addiction risks in opioid marketing
WECT 6 Wilmington / Posted 24 days ago
targeted the elderly and veterans, leading to "catastrophic results." The five companies are Janssen Pharmaceuticals, Purdue Pharma, Actavis, Endo Health Solutions Inc., and Teva Pharmaceutical Industries. The drugmakers have asked a federal... Read more
54 related stories
24d
ABC 7 Gulfshore News
Pfizer agrees to note addiction risks in opioid marketingtargeted the elderly and veterans, leading to "catastrophic results." The five
Pfizer agrees to note addiction risks in opioid marketing
ABC 7 Gulfshore News / Posted 24 days ago
targeted the elderly and veterans, leading to "catastrophic results." The five companies are Janssen Pharmaceuticals, Purdue Pharma, Actavis, Endo Health Solutions Inc., and Teva Pharmaceutical Industries. The drugmakers have asked a federal... Read more
54 related stories
24d
WSFA 12 Montgomery
Pfizer agrees to note addiction risks in opioid marketingtargeted the elderly and veterans, leading to "catastrophic results." The five
Pfizer agrees to note addiction risks in opioid marketing
WSFA 12 Montgomery / Posted 24 days ago
targeted the elderly and veterans, leading to "catastrophic results." The five companies are Janssen Pharmaceuticals, Purdue Pharma, Actavis, Endo Health Solutions Inc., and Teva Pharmaceutical Industries. The drugmakers have asked a federal... Read more
54 related stories
24d
The Record Searchlight
Pfizer agrees to note addiction risks in opioid marketingtargeted the elderly and veterans, leading to "catastrophic results." The five
Pfizer agrees to note addiction risks in opioid marketing
The Record Searchlight / Posted 24 days ago
targeted the elderly and veterans, leading to "catastrophic results." The five companies are Janssen Pharmaceuticals, Purdue Pharma, Actavis, Endo Health Solutions Inc., and Teva Pharmaceutical Industries. The drugmakers have asked a federal... Read more
54 related stories
24d
14 WFIE Evansville
Pfizer agrees to note addiction risks in opioid marketingtargeted the elderly and veterans, leading to "catastrophic results." The five
Pfizer agrees to note addiction risks in opioid marketing
14 WFIE Evansville / Posted 24 days ago
targeted the elderly and veterans, leading to "catastrophic results." The five companies are Janssen Pharmaceuticals, Purdue Pharma, Actavis, Endo Health Solutions Inc., and Teva Pharmaceutical Industries. The drugmakers have asked a federal... Read more
54 related stories
More

People in this news